Singapore, July 18, 2008: The third edition of Korea's largest biotechnology event, Bio Korea convention will be held October 8-10, 2008 at Osong Bio-Technopolis, located in the nation's idealist zone facilitated with the best bio-infrastructure, represents an outpost for Korea's bio industry.

 

The event of this year offers a variety of high-level conference, international exhibition and partnership events and provides an opportunity to find business and technology partners. It expects 350 companies and 25,000 visitors globally.

 

The Bio Korea 2008 conference will provide an opportunity to discuss various subjects such as vaccine, clinic, regenerative medicine, new medicine developed from natural substances, antibodies, technology commercialization, investment attraction, and industry policies and system with 39 sessions given by 125 world-class scholars and experts in life science and bio industry and CEOs of global bio companies, and share related knowledge and information.

 

The Korean bio-industry represents a substantial amount of growth. It has been grown by an average of 14 percent per year over the last three years. The great strides in the field of Korean bio-industry are attributed to the support and effort of government, academics, research institutes and companies from related industry. The Korean government is nurturing bio industries to become the core national strategic industry in the 21st century with pledge funds and policies.